News
SEMM Calls for PhD Programs
Jul 18, 2023The European School of Molecular Medicine (SEMM) offers 70 PhD positions in the Systems Medicine program!
Read MoreA large international investment in hereditary retinal diseases
Jun 06, 2023The path of AAVantgarde Bio, the Tigem spin-off dedicated to the development of gene therapies for hereditary diseases of the retina, continues at full speed! The company, founded in 2021 thanks to the Sofinnova-Telethon fund, has in fact announced that it has obtained a 61 million euro from three major international investment companies: Atlas Venture, Forbion and Longwood. AAVantgarde Bio will work to bring an innovative gene therapy approach born in the Telethon laboratories to the clinic.
Read MoreEUROPEAN RESEARCH COUNCIL (ERC): ASSIGNED TO ANDREA BALLABIO AND ALBERTO AURICCHIO TWO ADVANCED GRANTS FOR A TOTAL OF 5 MILLION EUROS
Mar 30, 2023Andrea Ballabio and Alberto Auricchio received the prestigious ERC Advanced Grants, also as evidence of excellence of the Telethon Institute of Genetics and Medicine, capable of attracting the best Italian and international scientists.
Read More